chief revenue officer

Contakt World Appoints Commercial and Software Expert Ricardo Lachac as Chief Revenue Officer

Contakt World Technologies Corp. (CSE: HELP) (OTC: TLOOF) (FSE: B2I) (the "Company" or "Contakt World") today announced the appointment of Ricardo Lachac to the position of Chief Revenue Officer.

Ricardo Lachac is a seasoned global multilingual executive with 30 years of experience, 20 in C-level, in Technology, Data, Analytics, and Risk Management leading go-to-market strategies and revenue growth. He was recently Vice President, Business Development & Chief Executive Officer, Brazil, for LexisNexis Risk Solutions (LNRS). Mr. Lachac launched LNRS Brazil, where the company had no footprint and quickly captured more than 50% of the market share in high-tech niches like Auto Insurance Telematics. Previously, he was Chief Operating Officer at Seguros Unimed, which belongs to the #1 Health System in Brazil and #1 Medical Co-Op globally, with 17MM customers. His career also includes executive positions at IBM, AIG and Indiana, a Liberty Mutual subsidiary. Mr. Lachac is an Electrical Engineer from the University of Sao Paulo (USP), with an MBA from Fundacao Getúlio Vargas (FGV) and The University of Texas at Austin.

"We welcome Ricardo to Contakt World and are privileged to have someone of his caliber and expertise in developing commercial divisions for technology companies serve as our Chief Revenue Officer," said Justin Beck, Founder and Chief Visionary Officer of Contakt World. "We believe Ricardo's broad experience in building sales volume with a strong dedication to customer satisfaction will be instrumental as we enter into the revenue phase with our first three customers with the Smart Health RM ready for private and public markets."

Newly appointed CRO Ricardo Lachac added, "Contakt World's value proposition using IoT, SaaS, and communications can have a tremendous impact on health outcomes and revenue generation within public and private sectors. It's a privilege to join the team and accelerate Contakt World's commercial plans."

About Contakt World

Contakt World is a technology company developing and delivering SaaS solutions for the public and private sectors. The company integrates data collection and management, communications, advertising, and IoT devices - providing customers with a scalable ecosystem that makes sense of people, place, time, and space for the emerging "phygital" (blending physical and digital) world. Contakt World is committed to improving health equity and disease management while solving sector-specific business challenges.

Contakt World Contact
Zayn Kalyan
Interim CEO and Director
Direct: 778-938-3367

For more information, please visit the Company's website at www.contakt.world.

Contakt World Investor Contact
Lucas A. Zimmerman
Senior Vice President - MZ North America
Direct: 949-259-4987
contakt@mzgroup.us
www.mzgroup.us

Forward-Looking Statements

Certain information set forth in this press release contains statements that reflect "forward-looking information", as such term is defined under Canadian securities laws ("forward-looking statements"). These forward-looking statements are often identified by words such as "intends", "anticipates", "expects", "believes", "plans", "likely" or similar words. Specifically, this news release includes forward-looking statements regarding the healthcare market and trends therein, the Company's sales efforts to date and execution of its three customer agreements, the Company's upcoming listing on the CSE and the Company's future business plans. The forward-looking statements reflect the Contakt World's management's expectations, estimates, or projections concerning future results or events, based on the opinions, assumptions and estimates considered reasonable by management at the date the statements are made. Although Contakt World believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements involve risks and uncertainties and undue reliance should not be placed on forward-looking statements, as unknown or unpredictable factors could cause actual results to be materially different from those reflected in the forward-looking statements. The forward-looking statements may also be affected by risks and uncertainties in the business of Contakt World, including those described in the Company's public filings available on www.SEDAR.com. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.

The Canadian Securities Exchange (CSE) has not reviewed, approved or disapproved the content

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/90971

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Syntheia Rings the Opening Bell on the Canadian Securities Exchange

Syntheia Rings the Opening Bell on the Canadian Securities Exchange

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, a Canadian leader in conversational AI, is pleased to announce that the Company's leadership team rang the bell to open the market in collaboration with the Canadian Securities Exchange to celebrate its successful listing under the symbol "SYAI".

" We look forward to great success through our partnership with the CSE as we commercially launch our conversational AI to the market. On behalf of the Company, I would like to thank everyone who has made this milestone happen, " commented Tony Di Benedetto, Chief Executive Officer at Syntheia.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Provaris Energy

Notice of Initial Substantial Holder - Regal Funds Management Pty Ltd

Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder.


Keep reading...Show less
Syntheia Set to Enhance Customer Communication with Its AI-Powered Virtual Assistant

Syntheia Set to Enhance Customer Communication with Its AI-Powered Virtual Assistant

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, a Canadian leader in conversational AI, announces that its innovative SaaS platform, designed to transform how businesses manage inbound telephone calls is set to launch in January of 2025. Leveraging advanced Natural Language Processing (NLP), Syntheia's virtual assistants enhance communication and efficiency targeting small and medium businesses in this large global marketplace.

" Our mission is to eliminate as many inefficiencies as we can with managing inbound calls that small to medium-sized businesses face utilizing the power of AI" said Tony Di Benedetto, CEO of Syntheia. "With AI-driven virtual assistants, we provide these businesses with tools to improve customer satisfaction while reducing operational costs. We are gearing up now for commercial launch in January of 2025, less than 8 weeks away."

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Canadian Securities Exchange Reports October 2024 Performance Figures

Canadian Securities Exchange Reports October 2024 Performance Figures

The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for October 2024.

October 2024 Operating Statistics

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update

Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro, has been invited to showcase Sona's developing Targeted Hyperthermia Therapy ("THT") cancer treatment today at the Nanotechnology Characterization Laboratory ("NCL"). Sona will be one of six commercial and academic collaborators to present its research at the NCL's 20th anniversary "Advancing Medical Applications of Cancer Nanotechnology" symposium. Sona's subsidiary was previously selected for the NCL Assay Cascade Program, the premier program in the World for bringing nanomaterials through critical preclinical stages and facilitating regulatory review, in which Sona's materials were assessed for biocompatibility. The NCL was established by the National Cancer Institute ("NCI") to accelerate the progress of nanomedicine by providing preclinical characterization and safety testing of nanoparticles. The NCL is a collaborative effort between NCI, the U.S. Food and Drug Administration ("FDA"), and the National Institute of Standards and Technology.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
XReality Group

Quarterly Activities Report and Appendix 4C - 30 Sept 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following Quarterly Activities Report and Appendix 4C for the quarter ending 30th September 2024 together with an Operational Update.

Keep reading...Show less

Latest Press Releases

Related News

×